These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2452456)

  • 21. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study.
    Luna D; Dulac O; Pajot N; Beaumont D
    Epilepsia; 1989; 30(4):430-7. PubMed ID: 2502384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy.
    Dam M
    Epilepsia; 1989; 30 Suppl 3():S26-30. PubMed ID: 2767017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.
    Loiseau P; Hardenberg JP; Pestre M; Guyot M; Schechter PJ; Tell GP
    Epilepsia; 1986; 27(2):115-20. PubMed ID: 3514204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic effects of gamma-vinyl GABA and carbamazepine.
    Mervaala E; Partanen J; Nousianinen U; Sivenius J; Riekkinen P
    Epilepsia; 1989; 30(2):189-93. PubMed ID: 2924744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.
    Halonen T; Pitkänen A; Saano V; Riekkinen PJ
    Epilepsia; 1991; 32(2):242-9. PubMed ID: 1672276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of gamma-vinyl GABA on interictal spikes and sharp waves in patients with intractable complex partial seizures.
    Ben-Menachem E; Treiman DM
    Epilepsia; 1989; 30(1):79-83. PubMed ID: 2912722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA in epilepsy: the pharmacologic basis.
    Gale K
    Epilepsia; 1989; 30 Suppl 3():S1-11. PubMed ID: 2548836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term study of gamma-vinyl GABA in the treatment of epilepsy.
    Pedersen SA; Klosterskov P; Gram L; Dam M
    Acta Neurol Scand; 1985 Sep; 72(3):295-8. PubMed ID: 4061051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from gamma-vinyl GABA (vigabatrin)-pretreated rats.
    Jackson MF; Esplin B; Capek R
    Neuropharmacology; 2000; 39(1):65-74. PubMed ID: 10665820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vigabatrin as an anticonvulsant against pentylenetetrazol seizures.
    Sayin U; Cengiz S; Altug T
    Pharmacol Res; 1993 Dec; 28(4):325-31. PubMed ID: 8140032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicentre study of vigabatrin for drug-resistant epilepsy.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; Miketta RM; Sherry KM; Szabo GK
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):95S-100S. PubMed ID: 2667606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients.
    Liegeois-Chauvel C; Marquis P; Gisselbrecht D; Pantieri R; Beaumont D; Chauvel P
    Epilepsia; 1989; 30 Suppl 3():S23-5. PubMed ID: 2767016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia.
    Bonnet AM; Esteguy M; Tell G; Schechter PJ; Hardenberg J; Agid Y
    Can J Neurol Sci; 1986 Nov; 13(4):331-3. PubMed ID: 3465425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. gamma Vinyl GABA: current role in the management of drug-resistant epilepsy.
    Treiman DM
    Epilepsia; 1989; 30 Suppl 3():S31-5. PubMed ID: 2767018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
    Neal MJ; Shah MA
    Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.